Search research articles
Contact Us
Filters
Showing results (131-140 of 156) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
July 1, 1982
Circulating immune complex levels in patients with gestational trophoblastic neoplasia
A A Rayner, R Berkowitz, G Steele, et al.
The Journal of Hospital Infection
|
February 26, 2008
Mycobacteria and allograft heart valve banking: an international survey
R M Warwick, J G Magee, J P Leeming, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721
F E Halberg, S M LaRue, A A Rayner, et al.
American Journal of Medical Genetics. Part A
|
October 16, 2007
Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal hernia
Anthony J Aldave, Vivek S Yellore, Fei Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1990
Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells
M H Bar, M Sznol, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1990
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen
D R Parkinson, R I Fisher, A A Rayner, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma
M J Hawkins, M B Atkins, J P Dutcher, et al.
Molecular Vision
|
October 26, 2007
Identification of mutations in UBIAD1 following exclusion of coding mutations in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy
Vivek S Yellore, M Ali Khan, Nirit Bourla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines
K A Margolin, A A Rayner, M J Hawkins, et al.
Journal of the National Cancer Institute
|
June 1, 1983
Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats
M L Rodrick, G Steele, D S Ross, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 156) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
July 1, 1982
Circulating immune complex levels in patients with gestational trophoblastic neoplasia
A A Rayner, R Berkowitz, G Steele, et al.
The Journal of Hospital Infection
|
February 26, 2008
Mycobacteria and allograft heart valve banking: an international survey
R M Warwick, J G Magee, J P Leeming, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 1991
Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721
F E Halberg, S M LaRue, A A Rayner, et al.
American Journal of Medical Genetics. Part A
|
October 16, 2007
Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal hernia
Anthony J Aldave, Vivek S Yellore, Fei Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1990
Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells
M H Bar, M Sznol, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1990
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen
D R Parkinson, R I Fisher, A A Rayner, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma
M J Hawkins, M B Atkins, J P Dutcher, et al.
Molecular Vision
|
October 26, 2007
Identification of mutations in UBIAD1 following exclusion of coding mutations in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy
Vivek S Yellore, M Ali Khan, Nirit Bourla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines
K A Margolin, A A Rayner, M J Hawkins, et al.
Journal of the National Cancer Institute
|
June 1, 1983
Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats
M L Rodrick, G Steele, D S Ross, et al.
Page
of 16